Sagebrush Partners with Southern Nevada Health District to Provide Syphilis Treatment

January 17, 2024 04:52 PM EST | By News File Corp
 Sagebrush Partners with Southern Nevada Health District to Provide Syphilis Treatment
Image source: News File Corp

Las Vegas, Nevada--(Newsfile Corp. - January 17, 2024) - As the United States struggles with a congenital syphilis epidemic and a shortage of the treatment medication Bicillin® L-A, Sagebrush Health ("Sagebrush") has announced that it will be assisting patients who tested positive for the sexually transmitted infection and are referred by the Southern Nevada Health District. The goal of Sagebrush's new program will be to lower the very high syphilis infection rates in Nevada, including among low-income patients, minorities who do not have access to health care, and expectant mothers.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/8668/194611_c154b9dbf402ab63_001.jpg


Sagebrush Health provides sexual health services that are comprehensive, accessible, and equitable.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8668/194611_c154b9dbf402ab63_001full.jpg

The number of babies born with syphilis in the United States increased sharply between 2012 and 2022, attributed to a lack of early access to high-quality prenatal care and preventative resources. In particular, Nevada ranked 5th for primary and secondary syphilis and ranked 9th for congenital syphilis rates in 2021. Between 2017-2021, the state saw a 99% increase in the rates of congenital syphilis. This surge in cases has contributed to the nationwide shortages of the treatment drug Bicillin® L-A. Concerned by this issue, the leadership at Sagebrush has partnered with the Southern Nevada Health District to provide treatment for patients with syphilis.

With the goal of lowering congenital syphilis rates, Sagebrush will also be providing screening for people who are at increased risk for syphilis. Additionally, Sagebrush is focused on the long-term prevention of syphilis, and in 2024, it will continue to expand its educational programs and free screenings for low-income patients.

Anyone who would like further information on syphilis, including how to be screened for the infection and receive treatment, is invited to reach out to Sagebrush at 725-300-0506.

About Sagebrush Health

Sagebrush Health is committed to providing accessible and comprehensive sexual health services nationwide, emphasizing health equity. It is dedicated to eliminating healthcare disparities by promoting social justice in healthcare and ensuring equal access. Sagebrush prioritizes community-engaged health improvement and adapts to meet the needs of its patients and communities. It strives to stay abreast of advancements in HIV, AIDS, STIs, and viral hepatitis so that it can eliminate new infections. Sagebrush's services, including free STD testing, PrEP, PEP, and copay coverage for medications, are aimed at individuals facing financial barriers.

For more information about how Sagebrush is achieving nationwide accessibility and equity in specialty healthcare services, please visit its website or contact:

Rodbel Rodriguez
Director of Community Relations and Engagement
[email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/194611


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.